The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
Repeat Offender Sentenced to 10 Years for Possession of Child Sexual
An Oklahoma man was sentenced last week to 10 years in prison for possession of child sexual abuse material. Read More
Alleged Leader of Sinaloa Cartel Faction Indicted in Chicago on
A federal grand jury has indicted an alleged leader of a violent faction of the Sinaloa Cartel in Mexico on terrorism, drug, and firearm charges,… BronAlleged Leader of Sinaloa Cartel Faction Indicted in Chicago on
Nevada Man Pleads Guilty to Promoting Fraudulent Tax Avoidance Scheme
A Nevada man pleaded guilty to advising clients to commit tax evasion. Read More